“The Food and Drug Administration (FDA) is stepping up its efforts to counter the growing epidemic of opioid addiction by approving the first generic version of the treatment drug Suboxone (naloxone).
FDA Commissioner Scott Gottlieb says making the drug in generic form will ensure that it reaches more people who need it. The drug is in the form of a thin film that is placed under a patient’s tongue.
“The FDA is also taking new steps to address the unfortunate stigma that’s sometimes associated with the use of opioid replacement therapy as a means to successfully treat addiction,” Gottlieb said. “Patients addicted to opioids who are eventually treated for that addiction, and successfully transition onto medicines like buprenorphine, aren’t swapping one addiction for another, as is sometimes unfortunately said. They’re able to regain control of their lives and end all of the destructive outcomes that come with being addicted to opioids.”
Source: ConsumerAffairs.com – June 15, 2018